Works matching IS 20457634 AND DT 2024 AND VI 13 AND IP 3


Results: 90
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.7033
    By:
    • Judd, Sandra;
    • Revon‐Riviere, Gabriel;
    • Grover, Stephanie A.;
    • Deyell, Rebecca J.;
    • Vanan, Magimairajan Issai;
    • Lewis, Victor A.;
    • Pecheux, Lucie;
    • Zorzi, Alexandra P.;
    • Goudie, Catherine;
    • Santiago, Raoul;
    • Tran, Thai Hoa;
    • Abbott, Lesleigh S.;
    • Brossard, Josee;
    • Moorehead, Paul;
    • Alvi, Saima;
    • Portwine, Carol;
    • Denburg, Avram;
    • Whitlock, James A.;
    • Cohen‐Gogo, Sarah;
    • Morgenstern, Daniel A.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.7003
    By:
    • Leroy, Harmony;
    • Gadaud, Noémie;
    • Bérard, Emilie;
    • Klein, Emilie;
    • Luquet, Isabelle;
    • Vial, Jean‐Philippe;
    • Rieu, Jean‐Baptiste;
    • Lechevalier, Nicolas;
    • Tavitian, Suzanne;
    • Leguay, Thibaut;
    • Largeaud, Laetitia;
    • Bidet, Audrey;
    • Delabesse, Eric;
    • Sarry, Audrey;
    • de Grande, Anne‐Charlotte;
    • Récher, Christian;
    • Pigneux, Arnaud;
    • Bertoli, Sarah;
    • Dumas, Pierre‐Yves
    Publication type:
    Article
    22
    23
    24

    An international multicenter study comparing COVID‐19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.6997
    By:
    • Shafat, Tali;
    • Grupel, Daniel;
    • Porges, Tzvika;
    • Abuhasira, Ran;
    • Belkin, Ana;
    • Deri, Ofir;
    • Oster, Yonatan;
    • Zahran, Shadi;
    • Horwitz, Ehud;
    • Horowitz, Netanel A.;
    • Khatib, Hazim;
    • Batista, Marjorie Vieira;
    • Cortez, Anita Cassoli;
    • Brosh‐Nissimov, Tal;
    • Segman, Yafit;
    • Ishay, Linor;
    • Cohen, Regev;
    • Atamna, Alaa;
    • Spallone, Amy;
    • Chemaly, Roy F.
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma.

    Published in:
    Cancer Medicine, 2024, v. 13, n. 3, p. 1, doi. 10.1002/cam4.6912
    By:
    • Monge, Cecilia;
    • Xie, Changqing;
    • Myojin, Yuta;
    • Coffman‐D'Annibale, Kelley L.;
    • Hrones, Donna;
    • Brar, Gagandeep;
    • Wang, Sophie;
    • Budhu, Anuradha;
    • Figg, William D.;
    • Cam, Maggie;
    • Finney, Richard;
    • Levy, Elliot B.;
    • Kleiner, David E.;
    • Steinberg, Seth M.;
    • Wang, Xin Wei;
    • Redd, Bernadette;
    • Wood, Bradford J.;
    • Greten, Tim F.
    Publication type:
    Article
    47
    48
    49
    50